BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 27050822)

  • 1. Associations Between
    Lee YH; Song GG
    Genet Test Mol Biomarkers; 2023 Sep; 27(9):277-283. PubMed ID: 37695811
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations of toll-like receptor polymorphisms with systemic lupus erythematosus: A meta-analysis.
    Lee YH; Song GG
    Heliyon; 2024 Mar; 10(6):e27987. PubMed ID: 38509975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of
    Asgari R; Yari K; Mansouri K; Bakhtiari M
    Biomed Rep; 2018 Apr; 8(4):391-395. PubMed ID: 29541461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders.
    Ozdemirkiran FG; Nalbantoglu S; Gokgoz Z; Payzin BK; Vural F; Cagirgan S; Berdeli A
    Arch Med Sci; 2017 Mar; 13(2):426-432. PubMed ID: 28261298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.
    Kahl L; Patel J; Layton M; Binks M; Hicks K; Leon G; Hachulla E; Machado D; Staumont-Sallé D; Dickson M; Condreay L; Schifano L; Zamuner S; van Vollenhoven RF;
    Lupus; 2016 Nov; 25(13):1420-1430. PubMed ID: 27055521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Study of an AFF1 Gene Polymorphism (rs340630) with Iranian Systemic Lupus Erythematosus Patients.
    Arabi E; Garshasbi M; Jamshidi AR; Khalesi R; Ahmadzadeh N; Akbarian M; Mahmoudi M
    Acta Reumatol Port; 2016; 41(1):68-73. PubMed ID: 27115110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility.
    Abdallah E; Waked E; Abdelwahab MA
    Kidney Res Clin Pract; 2016 Mar; 35(1):29-34. PubMed ID: 27069855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser.
    Scheinberg MA; Hislop CM; Martin RS
    Expert Opin Biol Ther; 2016; 16(5):723-33. PubMed ID: 27051973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue.
    Montorsi L; Pitcher MJ; Zhao Y; Dionisi C; Demonti A; Tull TJ; Dhami P; Ellis RJ; Bishop C; Sanderson JD; Jain S; D'Cruz D; Gibbons DL; Winkler TH; Bemark M; Ciccarelli FD; Spencer J
    Nat Commun; 2024 May; 15(1):4051. PubMed ID: 38744839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.
    Yan H; Hong Y; Cai Y
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apoptosis genes in PDCD1 but not PDCD1LG2, FAS, and FASLG with pediatric idiopathic uveitis in Han Chinese.
    Pang T; Du L; Li F; Liu Y; Ma X; Cao Q; Shi L; Li N; Kijlstra A; Yang P
    Pediatr Res; 2020 Mar; 87(4):634-638. PubMed ID: 31618754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
    Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
    BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling clinical systemic lupus erythematosus: similarities, differences and success stories.
    Celhar T; Fairhurst AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i88-i99. PubMed ID: 28013204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas Versatile Signaling and Beyond: Pivotal Role of Tyrosine Phosphorylation in Context-Dependent Signaling and Diseases.
    Chakrabandhu K; Hueber AO
    Front Immunol; 2016; 7():429. PubMed ID: 27799932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between the FAS -670 A/G, -1377 G/A, and FASL -844 T/C polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
    Lee YH; Song GG
    Clin Exp Rheumatol; 2016; 34(4):634-40. PubMed ID: 27050822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis.
    Lee YH; Lee HS; Choi SJ; Ji JD; Song GG
    Lupus; 2012 Jan; 21(1):60-7. PubMed ID: 22004976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
    Lee YH; Bae SC; Song GG
    Rheumatol Int; 2015 Jun; 35(6):953-61. PubMed ID: 25326335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
    Arasteh JM; Sarvestani EK; Aflaki E; Amirghofran Z
    Immunol Invest; 2010; 39(1):27-38. PubMed ID: 20064083
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.